• Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio

    5 days ago - By San Diego Biotechnology

    Company Expands on Issued Patent to Create Novel Approach to Selectively Killing Tumor Cells SAN DIEGO, Jan. 20, 2023 /PRNewswire/ - Regen BioPharma, Inc. and , a biotechnology company advancing...
    Read more ...